{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:53:18Z","timestamp":1781517198195,"version":"3.54.1"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00210-026-05130-1","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T02:11:13Z","timestamp":1772071873000},"page":"11073-11094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A comprehensive review on thermo-responsive targeted and functional therapy for management of rheumatoid arthritis"],"prefix":"10.1007","volume":"399","author":[{"given":"Huma","family":"Hameed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Sharf ud","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ahsan","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kainat","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huzaifa","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Salawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"7","key":"5130_CR1","doi-asserted-by":"publisher","first-page":"10018","DOI":"10.1002\/jcp.27860","volume":"234","author":"M Abbasi","year":"2019","unstructured":"Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, Aslani S (2019) Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol 234(7):10018\u201310031","journal-title":"J Cell Physiol"},{"issue":"5","key":"5130_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/polym14050925","volume":"14","author":"WH Abuwatfa","year":"2022","unstructured":"Abuwatfa WH, Awad NS, Pitt WG, Husseini GA (2022) Thermosensitive polymers and thermo-responsive liposomal drug delivery systems. Polymers 14(5):925","journal-title":"Polymers"},{"key":"5130_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105856","volume":"163","author":"SBN Agostini","year":"2021","unstructured":"Agostini SBN, Malta IHS, Rodrigues RF, Freitas JTJ, de Sousa Lino ME, Dos Santos RS, Elisei LS, Moraes TR, dos Reis Giusto LA, de Oliveira MK (2021) Preclinical evaluation of methotrexate-loaded polyelectrolyte complexes and thermosensitive hydrogels as treatment for rheumatoid arthritis. Eur J Pharm Sci 163:105856","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"5130_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1080\/1061186X.2018.1527337","volume":"27","author":"KS Ahmed","year":"2019","unstructured":"Ahmed KS, Hussein SA, Ali AH, Korma SA, Lipeng Q, Jinghua C (2019) Liposome: composition, characterisation, preparation, and recent innovation in clinical applications. J Drug Target 27(7):742\u2013761","journal-title":"J Drug Target"},{"key":"5130_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107398","volume":"93","author":"RD Alamri","year":"2021","unstructured":"Alamri RD, Elmeligy MA, Albalawi GA, Alquayr SM, Alsubhi SS, El-Ghaiesh SH (2021) Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: a comprehensive review. Int Immunopharmacol 93:107398","journal-title":"Int Immunopharmacol"},{"issue":"13","key":"5130_CR6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360\u20131372","journal-title":"JAMA"},{"key":"5130_CR7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10067-019-04813-w","volume":"39","author":"AM Alex","year":"2020","unstructured":"Alex AM, Kunkel G, Sayles H, Flautero Arcos JD, Mikuls TR, Kerr GS (2020) Exposure to ambient air pollution and autoantibody status in rheumatoid arthritis. Clin Rheumatol 39:761\u2013768","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5130_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1042\/BST20190803","volume":"48","author":"AM Alqarni","year":"2020","unstructured":"Alqarni AM, Zeidler MP (2020) How does methotrexate work? Biochem Soc Trans 48(2):559\u2013567","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"5130_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030136","volume":"10","author":"A Alsuraifi","year":"2018","unstructured":"Alsuraifi A, Curtis A, Lamprou DA, Hoskins C (2018) Stimuli responsive polymeric systems for cancer therapy. Pharmaceutics 10(3):136","journal-title":"Pharmaceutics"},{"issue":"7","key":"5130_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/gels8070454","volume":"8","author":"MJ Ansari","year":"2022","unstructured":"Ansari MJ, Rajendran RR, Mohanto S, Agarwal U, Panda K, Dhotre K, Manne R, Deepak A, Zafar A, Yasir M (2022) Poly (N-isopropylacrylamide)-based hydrogels for biomedical applications: a review of the state-of-the-art. Gels 8(7):454","journal-title":"Gels"},{"issue":"17","key":"5130_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/polym15173600","volume":"15","author":"M Arif","year":"2023","unstructured":"Arif M (2023) A critical review of palladium nanoparticles decorated in smart microgels. Polymers 15(17):3600","journal-title":"Polymers"},{"key":"5130_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biochi.2020.03.014","volume":"174","author":"A Avdeeva","year":"2020","unstructured":"Avdeeva A, Rubtsov Y, Dyikanov D, Popkova T, Nasonov E (2020) Regulatory T cells in patients with early untreated rheumatoid arthritis: phenotypic changes in the course of methotrexate treatment. Biochimie 174:9\u201317","journal-title":"Biochimie"},{"issue":"20","key":"5130_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205023","volume":"20","author":"Y Bedoui","year":"2019","unstructured":"Bedoui Y, Guillot X, S\u00e9lambarom J, Guiraud P, Giry C, Jaffar-Bandjee MC, Ralandison S, Gasque P (2019) Methotrexate an old drug with new tricks. Int J Mol Sci 20(20):5023","journal-title":"Int J Mol Sci"},{"key":"5130_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jconrel.2020.11.049","volume":"329","author":"E Bellotti","year":"2021","unstructured":"Bellotti E, Schilling AL, Little SR, Decuzzi P (2021) Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: a review. J Control Release 329:16\u201335","journal-title":"J Control Release"},{"issue":"3","key":"5130_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/rheumatology\/36.3.382","volume":"36","author":"S Box","year":"1997","unstructured":"Box S, Pullar T (1997) Sulphasalazine in the treatment of rheumatoid arthritis. Br J Rheumatol 36(3):382\u2013386","journal-title":"Br J Rheumatol"},{"issue":"3","key":"5130_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/BOR.0b013e328329c79d","volume":"21","author":"J Braun","year":"2009","unstructured":"Braun J, Rau R (2009) An update on methotrexate. Curr Opin Rheumatol 21(3):216\u2013223","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"5130_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000493390","volume":"27","author":"J Bullock","year":"2019","unstructured":"Bullock J, Rizvi SA, Saleh AM, Ahmed SS, Do DP, Ansari RA, Ahmed J (2019) Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract 27(6):501\u2013507","journal-title":"Med Princ Pract"},{"issue":"11","key":"5130_CR18","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/ard.60.11.1040","volume":"60","author":"L Carmona","year":"2001","unstructured":"Carmona L, Ballina J, Gabriel R, Laffon A (2001) The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 60(11):1040\u20131045","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5130_CR19","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1515\/epoly-2021-0085","volume":"21","author":"TD Carrillo-Castillo","year":"2021","unstructured":"Carrillo-Castillo TD, Luna-Velasco A, Zaragoza-Contreras EA, Castro-Carmona JS (2021) Thermosensitive hydrogel for in situ-controlled methotrexate delivery. E-Polymers 21(1):910\u2013920","journal-title":"E-Polymers"},{"issue":"8","key":"5130_CR20","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/rheumatology\/41.8.952","volume":"41","author":"M Carulli","year":"2002","unstructured":"Carulli M, Davies U (2002) Peripheral neuropathy: an unwanted effect of leflunomide? Rheumatology 41(8):952\u2013953","journal-title":"Rheumatology"},{"issue":"5","key":"5130_CR21","first-page":"858","volume":"37","author":"M Casal-Dominguez","year":"2019","unstructured":"Casal-Dominguez M, Pinal-Fernandez I, Huapaya J, Albayda J, Paik JJ, Johnson C, Silhan L, Mammen AL, Danoff SK, Christopher-Stine L (2019) Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome. Clin Exp Rheumatol 37(5):858\u2013861","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl 1","key":"5130_CR22","volume":"71","author":"ES Chan","year":"2013","unstructured":"Chan ES, Cronstein BN (2013) Mechanisms of action of methotrexate. Bulletin of the NYU Hospital for Joint Diseases 71(suppl 1):S5","journal-title":"Bulletin of the NYU Hospital for Joint Diseases"},{"issue":"7","key":"5130_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071725","volume":"10","author":"T-H Chang","year":"2022","unstructured":"Chang T-H, Wu C-S, Chiou S-H, Chang C-H, Liao H-J (2022) Adipose-derived stem cell exosomes as a novel anti-inflammatory agent and the current therapeutic targets for rheumatoid arthritis. Biomedicines 10(7):1725","journal-title":"Biomedicines"},{"issue":"6","key":"5130_CR24","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1136\/annrheumdis-2016-210711","volume":"76","author":"K Chatzidionysiou","year":"2017","unstructured":"Chatzidionysiou K, Emamikia S, Nam J, Ramiro S, Smolen J, van der Heijde D, Dougados M, Bijlsma J, Burmester G, Scholte M (2017) Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 76(6):1102\u20131107","journal-title":"Ann Rheum Dis"},{"key":"5130_CR25","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S283518","author":"W Chen","year":"2020","unstructured":"Chen W, Li Z, Wang Z, Gao H, Ding J, He Z (2020) Intraarticular injection of infliximab-loaded thermosensitive hydrogel alleviates pain and protects cartilage in rheumatoid arthritis. J Pain Res. https:\/\/doi.org\/10.2147\/JPR.S283518","journal-title":"J Pain Res"},{"issue":"4","key":"5130_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.mser.2008.04.004","volume":"62","author":"D Chow","year":"2008","unstructured":"Chow D, Nunalee ML, Lim DW, Simnick AJ, Chilkoti A (2008) Peptide-based biopolymers in biomedicine and biotechnology. Mater Sci Eng R Rep 62(4):125\u2013155","journal-title":"Mater Sci Eng R Rep"},{"issue":"3","key":"5130_CR27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/art.23284","volume":"58","author":"C Clavel","year":"2008","unstructured":"Clavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, Sebbag M, Serre G (2008) Induction of macrophage secretion of tumor necrosis factor \u03b1 through Fc\u03b3 receptor IIa engagement by rheumatoid arthritis\u2013specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 58(3):678\u2013688","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"3","key":"5130_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein BN, Aune TM (2020) Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol 16(3):145\u2013154","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"5130_CR29","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N (2014) The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1316\u20131322","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5130_CR30","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s40744-021-00354-4","volume":"8","author":"JR Curtis","year":"2021","unstructured":"Curtis JR, Chakravarty SD, Black S, Kafka S, Xu S, Langholff W, Parenti D, Greenspan A, Schwartzman S (2021) Incidence of infusion reactions and clinical effectiveness of intravenous golimumab versus infliximab in patients with rheumatoid arthritis: the real-world AWARE study. Rheumatol Ther 8(4):1551\u20131563","journal-title":"Rheumatol Ther"},{"issue":"1","key":"5130_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jbspin.2012.02.005","volume":"80","author":"S Dadoun","year":"2013","unstructured":"Dadoun S, Zeboulon-Ktorza N, Combescure C, Elhai M, Rozenberg S, Gossec L, Fautrel B (2013) Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint Bone Spine 80(1):29\u201333","journal-title":"Joint Bone Spine"},{"issue":"5","key":"5130_CR32","doi-asserted-by":"publisher","first-page":"040","DOI":"10.7324\/JAPS.2019.90505","volume":"9","author":"T Das","year":"2019","unstructured":"Das T, Prakash VM, Math PKT (2019) Injectable in situ gel of methotrexate for rheumatoid arthritis: development, in vitro and in vivo evaluation. J Appl Pharm Sci 9(5):040\u2013048","journal-title":"J Appl Pharm Sci"},{"key":"5130_CR33","doi-asserted-by":"crossref","unstructured":"Dastidar DG, Chakrabarti G (2019) Thermoresponsive drug delivery systems, characterization and application. Applications of Targeted Nano Drugs and Delivery Systems. Elsevier, pp 133\u2013155","DOI":"10.1016\/B978-0-12-814029-1.00006-5"},{"issue":"1","key":"5130_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69309-z","volume":"10","author":"D Deng","year":"2020","unstructured":"Deng D, Zhou J, Li M, Li S, Tian L, Zou J, Wang T, Wu J, Zeng F, Yang J (2020) Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study. Sci Rep 10(1):12339","journal-title":"Sci Rep"},{"key":"5130_CR35","doi-asserted-by":"publisher","unstructured":"Deshmukh R, Rahman MA, Dewangan B, Harwansh RK, Das Paul S, Kanwar IL, Garg A (2024) Thermosensitive in situ gel of nanosized apremilast: Development and assessment for rheumatoid arthritis treatment. Nano LIFE, 14(2). https:\/\/doi.org\/10.1142\/S1793984424500028","DOI":"10.1142\/S1793984424500028"},{"issue":"1","key":"5130_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.1365-2036.2002.01156.x","volume":"16","author":"O Dewit","year":"2002","unstructured":"Dewit O, Vanheuverzwyn R, Desager JP, Horsmans Y (2002) Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn\u2019s disease. Aliment Pharmacol Ther 16(1):79\u201385","journal-title":"Aliment Pharmacol Ther"},{"key":"5130_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.111597","volume":"201","author":"M Dhanka","year":"2021","unstructured":"Dhanka M, Pawar V, Chauhan DS, Jain NK, Prabhuraj R, Shetty C, Kumawat MK, Prasad R, Srivastava R (2021) Synthesis and characterization of an injectable microparticles integrated hydrogel composite biomaterial: in-vivo biocompatibility and inflammatory arthritis treatment. Colloids Surf B Biointerfaces 201:111597","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"4","key":"5130_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1039\/C9TB02052G","volume":"8","author":"F Doberenz","year":"2020","unstructured":"Doberenz F, Zeng K, Willems C, Zhang K, Groth T (2020) Thermoresponsive polymers and their biomedical application in tissue engineering\u2013a review. J Mater Chem B 8(4):607\u2013628","journal-title":"J Mater Chem B"},{"key":"5130_CR39","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1007\/s11606-019-05230-0","volume":"34","author":"KE Donahue","year":"2019","unstructured":"Donahue KE, Schulman ER, Gartlehner G, Jonas BL, Coker-Schwimmer E, Patel SV, Weber RP, Bann CM, Viswanathan M (2019) Comparative effectiveness of combining MTX with biologic drug therapy versus either MTX or biologics alone for early rheumatoid arthritis in adults: a systematic review and network meta-analysis. J Gen Intern Med 34:2232\u20132245","journal-title":"J Gen Intern Med"},{"issue":"1","key":"5130_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","volume":"73","author":"M Dougados","year":"2014","unstructured":"Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, El-Zorkany B, Emery P (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73(1):62\u201368","journal-title":"Ann Rheum Dis"},{"key":"5130_CR41","doi-asserted-by":"crossref","unstructured":"Elion GB (1972) Mechanisms of action of drugs affecting immune responses: significance of azathioprine metabolites, SAGE Publications","DOI":"10.1177\/003591577206500315"},{"key":"5130_CR42","volume-title":"xPharm: the comprehensive pharmacology reference","author":"S Enna","year":"2008","unstructured":"Enna S, Bylund DB (2008) xPharm: the comprehensive pharmacology reference. Elsevier, Boston, MA, USA"},{"key":"5130_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00393-018-0481-y","volume":"77","author":"C Fiehn","year":"2018","unstructured":"Fiehn C, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J (2018) S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs. Z Rheumatol 77:35\u201353","journal-title":"Z Rheumatol"},{"key":"5130_CR44","volume-title":"Kelley and Firestein\u2019s textbook of rheumatology","author":"GS Firestein","year":"2016","unstructured":"Firestein GS, Budd RC, Gabriel SE, McInnes IB, O\u2019Dell JR (2016) Kelley and Firestein\u2019s textbook of rheumatology. Elsevier Health Sciences"},{"issue":"7","key":"5130_CR45","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1517\/14712598.2010.493873","volume":"10","author":"R Fleischmann","year":"2010","unstructured":"Fleischmann R (2010) The efficacy and safety of golimumab in the treatment of arthritis. Expert Opin Biol Ther 10(7):1131\u20131143","journal-title":"Expert Opin Biol Ther"},{"key":"5130_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","volume":"332","author":"M Ghezzi","year":"2021","unstructured":"Ghezzi M, Pescina S, Padula C, Santi P, Del Favero E, Cant\u00f9 L, Nicoli S (2021) Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release 332:312\u2013336","journal-title":"J Control Release"},{"issue":"22","key":"5130_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225318","volume":"10","author":"JP Gisbert","year":"2021","unstructured":"Gisbert JP, Chaparro M (2021) Primary failure to an anti-TNF agent in inflammatory bowel disease: switch (to a second anti-TNF agent) or swap (for another mechanism of action)? J Clin Med 10(22):5318","journal-title":"J Clin Med"},{"issue":"2","key":"5130_CR48","first-page":"272","volume":"33","author":"SM Goodman","year":"2015","unstructured":"Goodman SM, Cronstein BN, Bykerk VP (2015) Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review. Clin Exp Rheumatol 33(2):272","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"5130_CR49","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/JLB.5RU0519-145R","volume":"106","author":"E Gremese","year":"2019","unstructured":"Gremese E, Alivernini S, Tolusso B, Zeidler MP, Ferraccioli G (2019) JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy. J Leukoc Biol 106(5):1063\u20131068","journal-title":"J Leukoc Biol"},{"issue":"33","key":"5130_CR50","doi-asserted-by":"publisher","first-page":"10382","DOI":"10.12998\/wjcc.v9.i33.10382","volume":"9","author":"TG Grillo","year":"2021","unstructured":"Grillo TG, Almeida LR, Beraldo RF, Marcondes MB, Queir\u00f3z DAR, da Silva DL, Quera R, Baima JP, Saad-Hossne R, Sassaki LY (2021) Heart failure as an adverse effect of infliximab for Crohn\u2019s disease: a case report and review of the literature. World J Clin Cases 9(33):10382","journal-title":"World J Clin Cases"},{"issue":"6","key":"5130_CR51","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41397-020-0168-z","volume":"20","author":"M Grk","year":"2020","unstructured":"Grk M, Milic V, Dolzan V, Maksimovic N, Damnjanovic T, Pjevic MD, Pesic M, Novakovic I, Jekic B (2020) Analysis of association of ADORA 2 A and ADORA 3 polymorphisms genotypes\/haplotypes with efficacy and toxicity of methotrexate in patients with rheumatoid arthritis. Pharmacogenomics J 20(6):784\u2013791","journal-title":"Pharmacogenomics J"},{"key":"5130_CR52","doi-asserted-by":"publisher","unstructured":"Gulrez SKH, Al-Assaf S, Phillips GO (2011) Hydrogels: Methods of preparation, characterisation and applications. In a carpi (Ed.), progress in molecular and environmental bioengineering \u2013 from analysis and modeling to technology applications. rijeka, croatia: InTech. pp 117-150. https:\/\/doi.org\/10.5772\/24553","DOI":"10.5772\/24553"},{"key":"5130_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/581631","author":"Y Guo","year":"2013","unstructured":"Guo Y, Lu N, Bai A (2013) Clinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent update. Biomed Res Int. https:\/\/doi.org\/10.1155\/2013\/581631","journal-title":"Biomed Res Int"},{"key":"5130_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106367","volume":"181","author":"P Haloi","year":"2023","unstructured":"Haloi P, Chawla S, Konkimalla VB (2023) Thermosensitive smart hydrogel of PEITC ameliorates the therapeutic efficacy in rheumatoid arthritis. Eur J Pharm Sci 181:106367","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"5130_CR55","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/08982104.2019.1668010","volume":"30","author":"C Has","year":"2020","unstructured":"Has C, Sunthar P (2020) A comprehensive review on recent preparation techniques of liposomes. J Liposome Res 30(4):336\u2013365","journal-title":"J Liposome Res"},{"issue":"26","key":"5130_CR56","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.1021\/ja010378c","volume":"123","author":"M Hoffmann","year":"2001","unstructured":"Hoffmann M, Rychlewski J, Chrzanowska M, Hermann T (2001) Mechanism of activation of an immunosuppressive drug: azathioprine. Quantum chemical study on the reaction of azathioprine with cysteine. J Am Chem Soc 123(26):6404\u20136409","journal-title":"J Am Chem Soc"},{"issue":"6","key":"5130_CR57","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/psp4.46","volume":"4","author":"AM Hopkins","year":"2015","unstructured":"Hopkins AM, Wiese MD, Proudman SM, O\u2019Doherty CE, Foster D, Upton RN (2015) Semiphysiologically based pharmacokinetic model of leflunomide disposition in rheumatoid arthritis patients. CPT Pharmacometrics Syst Pharmacol 4(6):362\u2013371","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"13","key":"5130_CR58","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1002\/pola.22751","volume":"46","author":"XN Huang","year":"2008","unstructured":"Huang XN, Du FS, Zhang B, Zhao JY, Li ZC (2008) Acid-labile, thermoresponsive (meth) acrylamide polymers with pendant cyclic acetal moieties. J Polym Sci A Polym Chem 46(13):4332\u20134343","journal-title":"J Polym Sci A Polym Chem"},{"issue":"11","key":"5130_CR59","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1136\/annrheumdis-2021-220512","volume":"80","author":"S Jain","year":"2021","unstructured":"Jain S, Dhir V, Aggarwal A, Gupta R, Leishangthem B, Naidu S, Khullar A, Maurya S, Dhawan V, Sharma SK (2021) Comparison of two dose escalation strategies of methotrexate in active rheumatoid arthritis: a multicentre, parallel group, randomised controlled trial. Ann Rheum Dis 80(11):1376\u20131384","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5130_CR60","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1517\/13543770902769617","volume":"19","author":"X-J Ju","year":"2009","unstructured":"Ju X-J, Xie R, Yang L, Chu L-Y (2009) Biodegradable \u2018intelligent\u2019 materials in response to chemical stimuli for biomedical applications. Expert Opin Ther Pat 19(5):683\u2013696","journal-title":"Expert Opin Ther Pat"},{"issue":"12","key":"5130_CR61","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3899\/jrheum.160420","volume":"43","author":"J Kay","year":"2016","unstructured":"Kay J, Fleischmann R, Keystone E, Hsia EC, Hsu B, Zhou Y, Goldstein N, Braun J (2016) Five-year safety data from 5 clinical trials of subcutaneous golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 43(12):2120\u20132130","journal-title":"J Rheumatol"},{"issue":"2","key":"5130_CR62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1210\/er.2007-0014","volume":"29","author":"AE Kearns","year":"2008","unstructured":"Kearns AE, Khosla S, Kostenuik PJ (2008) Receptor activator of nuclear factor \u03baB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29(2):155\u2013192","journal-title":"Endocr Rev"},{"issue":"6","key":"5130_CR63","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.nano.2010.05.005","volume":"6","author":"U Kedar","year":"2010","unstructured":"Kedar U, Phutane P, Shidhaye S, Kadam V (2010) Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine Nanotechnol Biol Med 6(6):714\u2013729","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"issue":"9","key":"5130_CR64","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1177\/106002809603000906","volume":"30","author":"DT Kennedy","year":"1996","unstructured":"Kennedy DT, Hayney MS, Lake KD (1996) Azathioprine and allopurinol: the price of an avoidable drug interaction. Ann Pharmacother 30(9):951\u2013954","journal-title":"Ann Pharmacother"},{"key":"5130_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2011.01.014","author":"L Klareskog","year":"2011","unstructured":"Klareskog L, Malmstr\u00f6m V, Lundberg K, Padyukov L, Alfredsson L (2011) Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Seminars in Immunology, Elsevier. https:\/\/doi.org\/10.1016\/j.smim.2011.01.014","journal-title":"Seminars in Immunology, Elsevier"},{"issue":"20","key":"5130_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222010922","volume":"22","author":"N Kondo","year":"2021","unstructured":"Kondo N, Kuroda T, Kobayashi D (2021) Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci 22(20):10922","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5130_CR67","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0169-409X(96)00401-2","volume":"21","author":"GS Kwon","year":"1996","unstructured":"Kwon GS, Okano T (1996) Polymeric micelles as new drug carriers. Adv Drug Deliv Rev 21(2):107\u2013116","journal-title":"Adv Drug Deliv Rev"},{"key":"5130_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.110862","volume":"111","author":"K Lavanya","year":"2020","unstructured":"Lavanya K, Chandran SV, Balagangadharan K, Selvamurugan N (2020) Temperature-and pH-responsive chitosan-based injectable hydrogels for bone tissue engineering. Mater Sci Eng C Mater Biol 111:110862","journal-title":"Mater Sci Eng C Mater Biol"},{"issue":"7","key":"5130_CR69","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3346\/jkms.2017.32.7.1207","volume":"32","author":"J-E Lee","year":"2017","unstructured":"Lee J-E, Kim IJ, Cho M-S, Lee J (2017) A case of rheumatoid vasculitis involving hepatic artery in early rheumatoid arthritis. J Korean Med Sci 32(7):1207\u20131210","journal-title":"J Korean Med Sci"},{"issue":"3","key":"5130_CR70","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.42730","volume":"76","author":"K Lend","year":"2023","unstructured":"Lend K, Koopman FA, Lampa J, Jansen G, Uhlig T, Nordstr\u00f6m D, Nurmohamed M, Gudbjornsson B, Rudin A, \u00d8stergaard M (2023) Methotrexate safety and efficacy in combination therapies in patients with early rheumatoid arthritis: a post-hoc analysis of a randomized controlled trial (NORD-STAR). Arthritis Rheumatol 76(3):363\u2013373","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"5130_CR71","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/pat.1813","volume":"22","author":"V Leung","year":"2011","unstructured":"Leung V, Ko F (2011) Biomedical applications of nanofibers. Polym Adv Technol 22(3):350\u2013365","journal-title":"Polym Adv Technol"},{"issue":"4","key":"5130_CR72","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0149-2918(04)90048-3","volume":"26","author":"EK Li","year":"2004","unstructured":"Li EK, Tam L-S, Tomlinson B (2004) Leflunomide in the treatment of rheumatoid arthritis. Clin Ther 26(4):447\u2013459","journal-title":"Clin Ther"},{"key":"5130_CR73","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jconrel.2021.11.019","volume":"341","author":"H Li","year":"2022","unstructured":"Li H, Feng Y, Zheng X, Jia M, Mei Z, Wang Y, Zhang Z, Zhou M, Li C (2022) M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. J Control Release 341:16\u201330","journal-title":"J Control Release"},{"issue":"3","key":"5130_CR74","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/BOR.0b013e32832a2e16","volume":"21","author":"KP Liao","year":"2009","unstructured":"Liao KP, Alfredsson L, Karlson EW (2009) Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 21(3):279","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"5130_CR75","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pop.2018.02.010","volume":"45","author":"EA Littlejohn","year":"2018","unstructured":"Littlejohn EA, Monrad SU (2018) Early diagnosis and treatment of rheumatoid arthritis. Prim Care Clin Office Pract 45(2):237\u2013255","journal-title":"Prim Care Clin Office Pract"},{"issue":"6","key":"5130_CR76","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1021\/acsmacrolett.0c00342","volume":"9","author":"G-F Luo","year":"2020","unstructured":"Luo G-F, Chen W-H, Zhang X-Z (2020) 100th anniversary of macromolecular science viewpoint: poly (N-isopropylacrylamide)-based thermally responsive micelles. ACS Macro Lett 9(6):872\u2013881","journal-title":"ACS Macro Lett"},{"key":"5130_CR77","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s323107","author":"X Lv","year":"2021","unstructured":"Lv X, Wang L, Zou X, Huang S (2021) Umbilical cord mesenchymal stem cell therapy for regenerative treatment of rheumatoid arthritis: opportunities and challenges. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/dddt.s323107","journal-title":"Drug Des Devel Ther"},{"key":"5130_CR78","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jconrel.2014.06.028","volume":"190","author":"SR MacEwan","year":"2014","unstructured":"MacEwan SR, Chilkoti A (2014) Applications of elastin-like polypeptides in drug delivery. J Control Release 190:314\u2013330","journal-title":"J Control Release"},{"key":"5130_CR79","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1007\/s11033-020-05481-9","volume":"47","author":"V Maksimovic","year":"2020","unstructured":"Maksimovic V, Pavlovic-Popovic Z, Vukmirovic S, Cvejic J, Mooranian A, Al-Salami H, Mikov M, Golocorbin-Kon S (2020) Molecular mechanism of action and pharmacokinetic properties of methotrexate. Mol Biol Rep 47:4699\u20134708","journal-title":"Mol Biol Rep"},{"issue":"9","key":"5130_CR80","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/1756-185X.12862","volume":"19","author":"AN Malaviya","year":"2016","unstructured":"Malaviya AN (2016) Landmark papers on the discovery of methotrexate for the treatment of rheumatoid arthritis and other systemic inflammatory rheumatic diseases: a fascinating story. Int J Rheum Dis 19(9):844\u2013851","journal-title":"Int J Rheum Dis"},{"key":"5130_CR81","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF00301258","volume":"13","author":"A Malaviya","year":"1993","unstructured":"Malaviya A, Kapoor S, Singh R, Kumar A, Pande I (1993) Prevalence of rheumatoid arthritis in the adult Indian population. Rheumatol Int 13:131\u2013134","journal-title":"Rheumatol Int"},{"issue":"2","key":"5130_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10158","volume":"5","author":"A Mandal","year":"2020","unstructured":"Mandal A, Clegg JR, Anselmo AC, Mitragotri S (2020) Hydrogels in the clinic. Bioeng Transl Med 5(2):e10158","journal-title":"Bioeng Transl Med"},{"issue":"16","key":"5130_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/polym13162639","volume":"13","author":"L Marsili","year":"2021","unstructured":"Marsili L, Dal Bo M, Eisele G, Donati I, Berti F, Toffoli G (2021) Characterization of thermoresponsive poly-N-vinylcaprolactam polymers for biological applications. Polymers 13(16):2639","journal-title":"Polymers"},{"issue":"3","key":"5130_CR84","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/app.34332","volume":"122","author":"B Miao","year":"2011","unstructured":"Miao B, Song C, Ma G (2011) Injectable thermosensitive hydrogels for intra-articular delivery of methotrexate. J Appl Polym Sci 122(3):2139\u20132145","journal-title":"J Appl Polym Sci"},{"issue":"11","key":"5130_CR85","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00296-020-04694-2","volume":"40","author":"DP Misra","year":"2020","unstructured":"Misra DP, Gasparyan AY, Zimba O (2020) Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatol Int 40(11):1741\u20131751","journal-title":"Rheumatol Int"},{"key":"5130_CR86","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40264-020-00955-y","volume":"43","author":"J-L Montastruc","year":"2020","unstructured":"Montastruc J-L, Toutain P-L (2020) A new drug\u2013drug interaction between hydroxychloroquine and metformin? A signal detection study. Drug Saf 43:657\u2013660","journal-title":"Drug Saf"},{"issue":"5","key":"5130_CR87","first-page":"S85","volume":"28","author":"O Morgaceva","year":"2010","unstructured":"Morgaceva O, Furst D (2010) Use of MTX in the elderly and in patients with compromised renal function. Clin Exp Rheumatol 28(5):S85","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"5130_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113017","volume":"10","author":"A-L Mueller","year":"2021","unstructured":"Mueller A-L, Payandeh Z, Mohammadkhani N, Mubarak SM, Zakeri A, Alagheband Bahrami A, Brockmueller A, Shakibaei M (2021) Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies. Cells 10(11):3017","journal-title":"Cells"},{"key":"5130_CR89","doi-asserted-by":"crossref","unstructured":"Nagati V, Tenugu S, Pasupulati AK (2022) Stability of therapeutic nano-drugs during storage and transportation as well as after ingestion in the human body. Advances in Nanotechnology-Based Drug Delivery Systems. Elsevier, pp 83\u2013102","DOI":"10.1016\/B978-0-323-88450-1.00020-X"},{"issue":"4","key":"5130_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/diseases5040027","volume":"5","author":"AA Naqvi","year":"2017","unstructured":"Naqvi AA, Hassali MA, Aftab MT, Naqvi SBS, Zehra F, Ahmad R, Ahmad N (2017) Development of evidence-based disease education literature for Pakistani rheumatoid arthritis patients. Diseases 5(4):27","journal-title":"Diseases"},{"issue":"2","key":"5130_CR91","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/0040517511424524","volume":"82","author":"R Nayak","year":"2012","unstructured":"Nayak R, Padhye R, Kyratzis IL, Truong YB, Arnold L (2012) Recent advances in nanofibre fabrication techniques. Text Res J 82(2):129\u2013147","journal-title":"Text Res J"},{"issue":"2","key":"5130_CR92","first-page":"905","volume":"18","author":"RI Nedelcu","year":"2019","unstructured":"Nedelcu RI, Balaban M, Turcu G, Brinzea A, Ion DA, Antohe M, Hodorogea A, Calinescu A, Badarau AI, Popp CG (2019) Efficacy of methotrexate as anti\u2011inflammatory and anti\u2011proliferative drug in dermatology: three case reports. Exp Ther Med 18(2):905\u2013910","journal-title":"Exp Ther Med"},{"key":"5130_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12348-020-00202-6","volume":"10","author":"F Nicolela Susanna","year":"2020","unstructured":"Nicolela Susanna F, Pavesio C (2020) A review of ocular adverse events of biological anti-TNF drugs. J Ophthalmic Inflamm Infect 10:1\u20139","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"5130_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71676-6","volume":"10","author":"T Ohno","year":"2020","unstructured":"Ohno T, Aune D, Heath AK (2020) Adiposity and the risk of rheumatoid arthritis: a systematic review and meta-analysis of cohort studies. Sci Rep 10(1):16006","journal-title":"Sci Rep"},{"issue":"7","key":"5130_CR95","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-021-06547-1","volume":"32","author":"IM Oliveira","year":"2021","unstructured":"Oliveira IM, Fernandes DC, Cengiz IF, Reis RL, Oliveira JM (2021) Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models. J Mater Sci Mater Med 32(7):74","journal-title":"J Mater Sci Mater Med"},{"key":"5130_CR96","doi-asserted-by":"crossref","unstructured":"Osawa K, Kiniwa Y, Shimosato Y, Midorikawa H, Shirai T, Tasuku S, Nakamura K, Okuyama\u00a0R (2022) Toxic epidermal necrolysis caused by apalutamide: a case report of treatment using etanercept with conventional steroid therapy. Acta Dermato-Venereol 102:adv00723","DOI":"10.2340\/actadv.v102.2243"},{"issue":"5","key":"5130_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.101477","volume":"33","author":"T Ot\u00f3n","year":"2019","unstructured":"Ot\u00f3n T, Carmona L (2019) The epidemiology of established rheumatoid arthritis. Best Pract Res Clin Rheumatol 33(5):101477","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5130_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119851","volume":"239","author":"W Pan","year":"2020","unstructured":"Pan W, Dai C, Li Y, Yin Y, Gong L, Machuki JOa, Yang Y, Qiu S, Guo K, Gao F (2020) PRP-chitosan thermoresponsive hydrogel combined with black phosphorus nanosheets as injectable biomaterial for biotherapy and phototherapy treatment of rheumatoid arthritis. Biomaterials 239:119851","journal-title":"Biomaterials"},{"key":"5130_CR99","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/313858","author":"M Patan\u00e8","year":"2013","unstructured":"Patan\u00e8 M, Ciriaco M, Chimirri S, Ursini F, Naty S, Grembiale RD, Gallelli L, De Sarro G, Russo E (2013) Interactions among low dose of methotrexate and drugs used in the treatment of rheumatoid arthritis. Adv Pharmacol Sci. https:\/\/doi.org\/10.1155\/2013\/313858","journal-title":"Adv Pharmacol Sci"},{"issue":"3","key":"5130_CR100","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jaad.2005.07.059","volume":"55","author":"AA Patel","year":"2006","unstructured":"Patel AA, Swerlick RA, McCall CO (2006) Azathioprine in dermatology: the past, the present, and the future. J Am Acad Dermatol 55(3):369\u2013389","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"5130_CR101","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/jcm8030387","volume":"8","author":"E Pelechas","year":"2019","unstructured":"Pelechas E, Voulgari PV, Drosos AA (2019) Golimumab for rheumatoid arthritis. J Clin Med 8(3):387","journal-title":"J Clin Med"},{"key":"5130_CR102","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021222","author":"T Qi","year":"2020","unstructured":"Qi T, Gao H, Dang Y, Huang S, Peng M (2020) Cervus and cucumis peptides combined umbilical cord mesenchymal stem cells therapy for rheumatoid arthritis. Medicine. https:\/\/doi.org\/10.1097\/MD.0000000000021222","journal-title":"Medicine"},{"key":"5130_CR103","doi-asserted-by":"publisher","unstructured":"Jayaraman K, Kotaki M, Zhang Y, Mo X, Ramakrishna S (2004) Recent advances in polymer nanofibers.\u00a0J Nanosci Nanotechnol 4(1\u20132):52\u201365. https:\/\/doi.org\/10.1166\/jnn.2004.078","DOI":"10.1166\/jnn.2004.078"},{"issue":"1","key":"5130_CR104","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1038\/s41598-020-60305-x","volume":"10","author":"C Regueiro","year":"2020","unstructured":"Regueiro C, Rodriguez-Rodriguez L, Lopez-Mejias R, Nu\u00f1o L, Triguero-Martinez A, Perez-Pampin E, Corrales A, Villalba A, Lopez-Golan Y, Abasolo L (2020) A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis. Sci Rep 10(1):3355","journal-title":"Sci Rep"},{"key":"5130_CR105","first-page":"132","volume":"60","author":"ETD Reis Neto","year":"2020","unstructured":"Reis Neto ETD, Kakehasi AM, Pinheiro MDM, Ferreira GA, Marques CDL, MotaLMHD Paiva EDS, Pileggi GCS, Sato EI, Reis APMG (2020) Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases. Adv Rheumatol 60:132","journal-title":"Adv Rheumatol"},{"key":"5130_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4398","volume":"15","author":"S Revu","year":"2013","unstructured":"Revu S, Nereg\u00e5rd P, af Klint E, Korotkova M, Catrina AI (2013) Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. Arthritis Res Ther 15:1\u201310","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"5130_CR107","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1046\/j.1365-2036.2003.01778.x","volume":"18","author":"X Roblin","year":"2003","unstructured":"Roblin X, Serre-Debeauvais F, Phelip J-M, Bessard G, Bonaz B (2003) Drug interaction between infliximab and azathioprine in patients with Crohn\u2019s disease. Aliment Pharmacol Ther 18(9):917\u2013925","journal-title":"Aliment Pharmacol Ther"},{"key":"5130_CR108","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00296-014-2974-6","volume":"34","author":"M Rossini","year":"2014","unstructured":"Rossini M, Rossi E, Bernardi D, Viapiana O, Gatti D, Idolazzi L, Caimmi C, DeRosa M, Adami S (2014) Prevalence and incidence of rheumatoid arthritis in Italy. Rheumatol Int 34:659\u2013664","journal-title":"Rheumatol Int"},{"issue":"1","key":"5130_CR109","first-page":"117","volume":"34","author":"CH Roux","year":"2007","unstructured":"Roux CH, Saraux A, Le Bihan E, Fardellone P, Guggenbuhl P, Fautrel B, Masson C, Chary-Valckenaere I, Cantagrel A, Juvin R (2007) Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France. J Rheumatol 34(1):117\u2013122","journal-title":"J Rheumatol"},{"issue":"2","key":"5130_CR110","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/03009742.2022.2028364","volume":"52","author":"J Ruwaard","year":"2023","unstructured":"Ruwaard J, l\u2019Ami M, Kneepkens E, Krieckaert C, Nurmohamed M, Hooijberg F, van Kuijk A, van Denderen J, Burgemeister L, Rispens T (2023) Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial. Scand J Rheumatol 52(2):129\u2013136","journal-title":"Scand J Rheumatol"},{"key":"5130_CR111","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10067-020-05235-9","volume":"40","author":"RM Salem","year":"2021","unstructured":"Salem RM, El-Deeb A, Elsergany M, Elsaadany H, El-Khouly R (2021) Intra-articular injection of etanercept versus glucocorticoids in rheumatoid arthritis patients. Clin Rheumatol 40:557\u2013564","journal-title":"Clin Rheumatol"},{"key":"5130_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101549","volume":"56","author":"S Saraf","year":"2020","unstructured":"Saraf S, Jain A, Tiwari A, Verma A, Panda PK, Jain SK (2020) Advances in liposomal drug delivery to cancer: an overview. J Drug Deliv Sci Technol 56:101549","journal-title":"J Drug Deliv Sci Technol"},{"key":"5130_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fmats.2020.00073","volume":"7","author":"T Sarwan","year":"2020","unstructured":"Sarwan T, Kumar P, Choonara YE, Pillay V (2020) Hybrid thermo-responsive polymer systems and their biomedical applications. Front Mater 7:73","journal-title":"Front Mater"},{"issue":"3","key":"5130_CR114","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5582\/ddt.2019.01032","volume":"13","author":"Y Sawai","year":"2019","unstructured":"Sawai Y, Katsuya Y, Shinozaki-Ushiku A, Iwasaki A, Fukayama M, Watanabe K, Nagase T (2019) Rapid temporal improvement of pembrolizumab-induced pneumonitis using the anti-TNF-\u03b1 antibody infliximab. Drug Discov Ther 13(3):164\u2013167","journal-title":"Drug Discov Ther"},{"issue":"1","key":"5130_CR115","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/rheumatology\/key275","volume":"58","author":"L Schapink","year":"2019","unstructured":"Schapink L, van den Ende CH, Gevers LA, van Ede AE, den Broeder AA (2019) The effects of methotrexate and hydroxychloroquine combination therapy vs methotrexate monotherapy in early rheumatoid arthritis patients. Rheumatology 58(1):131\u2013134","journal-title":"Rheumatology"},{"issue":"3","key":"5130_CR116","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16(3):155\u2013166","journal-title":"Nat Rev Rheumatol"},{"issue":"28","key":"5130_CR117","doi-asserted-by":"publisher","first-page":"24984","DOI":"10.1021\/acsami.9b04979","volume":"11","author":"J Seo","year":"2019","unstructured":"Seo J, Park SH, Kim MJ, Ju HJ, Yin XY, Min BH, Kim MS (2019) Injectable click-crosslinked hyaluronic acid depot to prolong therapeutic activity in articular joints affected by rheumatoid arthritis. ACS Appl Mater Interfaces 11(28):24984\u201324998","journal-title":"ACS Appl Mater Interfaces"},{"key":"5130_CR118","doi-asserted-by":"publisher","unstructured":"Seoane-Mato D, S\u00e1nchez-Piedra C, Silva-Fern\u00e1ndez L, Sivera F, Blanco FJ, P\u00e9rez Ruiz F, D\u00edaz-Gonz\u00e1lez F, Bustabad S (2019) Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology. Reumatolog\u00eda Cl\u00ednica (English Edition) 15(2):90\u201396. https:\/\/doi.org\/10.1016\/j.reuma.2017.06.009","DOI":"10.1016\/j.reuma.2017.06.009"},{"key":"5130_CR119","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01669-2","author":"S Sharma","year":"2025","unstructured":"Sharma S, Ghosh R, Marianesan AB, Hussain S, Pandey JD, Kumar M (2025) Nanostructured lipid carriers in rheumatoid arthritis: treatment, advancements and applications. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-025-01669-2","journal-title":"Inflammopharmacology"},{"issue":"9","key":"5130_CR120","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1093\/rheumatology\/keab304","volume":"60","author":"AA Sherbini","year":"2021","unstructured":"Sherbini AA, Sharma SD, Gwinnutt JM, Hyrich KL, Verstappen SM (2021) Prevalence and predictors of adverse events with methotrexate mono-and combination-therapy for rheumatoid arthritis: a systematic review. Rheumatology 60(9):4001\u20134017","journal-title":"Rheumatology"},{"issue":"57","key":"5130_CR121","doi-asserted-by":"publisher","first-page":"7632","DOI":"10.1039\/c4cc02595d","volume":"50","author":"JM Shin","year":"2014","unstructured":"Shin JM, Kim S-H, Thambi T, You DG, Jeon J, Lee JO, Chung BY, Jo D-G, Park JH (2014) A hyaluronic acid\u2013methotrexate conjugate for targeted therapy of rheumatoid arthritis. Chem Commun 50(57):7632\u20137635","journal-title":"Chem Commun"},{"key":"5130_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.213853","volume":"160","author":"R Singh","year":"2024","unstructured":"Singh R, Jadhav K, Kamboj R, Malhotra H, Ray E, Jhilta A, Dhir V, Verma RK (2024) Self-actuating inflammation responsive hydrogel microsphere formulation for controlled drug release in rheumatoid arthritis (RA): animal trials and study in human fibroblast like synoviocytes (hFLS) of RA patients. Biomaterials Advances 160:213853","journal-title":"Biomaterials Advances"},{"key":"5130_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2021.102563","volume":"299","author":"P Singla","year":"2022","unstructured":"Singla P, Garg S, McClements J, Jamieson O, Peeters M, Mahajan RK (2022) Advances in the therapeutic delivery and applications of functionalized Pluronics: a critical review. Adv Colloid Interface Sci 299:102563","journal-title":"Adv Colloid Interface Sci"},{"issue":"3","key":"5130_CR124","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/rheumatology\/ket446","volume":"53","author":"S Slimani","year":"2014","unstructured":"Slimani S, Ladjouze-Rezig A (2014) Prevalence of rheumatoid arthritis in an urban population of Algeria: a prospective study. Rheumatology 53(3):571\u2013573","journal-title":"Rheumatology"},{"issue":"9149","key":"5130_CR125","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0140-6736(98)09403-3","volume":"353","author":"JS Smolen","year":"1999","unstructured":"Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. Lancet 353(9149):259\u2013266","journal-title":"Lancet"},{"key":"5130_CR126","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"J Smolen","year":"2016","unstructured":"Smolen J, Aletaha D, McInnes I (2016a) Rheumatoid arthritis. Lancet 388:2023\u20132038","journal-title":"Lancet"},{"issue":"1","key":"5130_CR127","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Comp\u00e1n MV, Oliver S, Schoels M (2016b) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75(1):3\u201315","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5130_CR128","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landew\u00e9 R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, Van Vollenhoven R (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960\u2013977","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5130_CR129","doi-asserted-by":"publisher","first-page":"369","DOI":"10.7326\/M19-3369","volume":"172","author":"DH Solomon","year":"2020","unstructured":"Solomon DH, Glynn RJ, Karlson EW, Lu F, Corrigan C, Colls J, Xu C, MacFadyen J, Barbhaiya M, Berliner N (2020) Adverse effects of low-dose methotrexate: a randomized trial. Ann Intern Med 172(6):369\u2013380","journal-title":"Ann Intern Med"},{"key":"5130_CR130","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s165440","author":"R Song","year":"2018","unstructured":"Song R, Murphy M, Li C, Ting K, Soo C, Zheng Z (2018) Current development of biodegradable polymeric materials for biomedical applications. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/dddt.s165440","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"5130_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-021-04651-5","volume":"22","author":"MM Sullivan","year":"2021","unstructured":"Sullivan MM, Pham MM, Marks LA, Aslam F (2021) Intra-articular therapy with methotrexate or tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic review. BMC Musculoskelet Disord 22(1):1\u201310","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"5130_CR132","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.intimp.2013.11.014","volume":"18","author":"Y Sun","year":"2014","unstructured":"Sun Y, Yao Y, Ding C-z (2014) A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines. Int Immunopharmacol 18(1):135\u2013141","journal-title":"Int Immunopharmacol"},{"key":"5130_CR133","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00005-015-0338-x","volume":"63","author":"J \u015awierkot","year":"2015","unstructured":"\u015awierkot J, Gruszecka K, Matuszewska A, Wiland P (2015) Assessment of the effect of methotrexate therapy on bone metabolism in patients with rheumatoid arthritis. Arch Immunol Ther Exp 63:397\u2013404","journal-title":"Arch Immunol Ther Exp"},{"key":"5130_CR134","doi-asserted-by":"crossref","unstructured":"Tanioka A, Takahashi M (2016) Nanofibers. High-performance and specialty fibers: concepts, technology and modern applications of man-made fibers for the future. S. The Society of Fiber and J. Techno. Tokyo, Springer Japan: 273\u2013283","DOI":"10.1007\/978-4-431-55203-1_16"},{"issue":"3","key":"5130_CR135","doi-asserted-by":"publisher","first-page":"445","DOI":"10.55563\/clinexprheumatol\/j1l5l3","volume":"39","author":"D Testa","year":"2021","unstructured":"Testa D, Calvacchi S, Petrelli F, Giannini D, Bilia S, Alunno A, Puxeddu I (2021) One year in review 2021: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 39(3):445\u2013452","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"5130_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130078","volume":"10","author":"S Thomas","year":"2015","unstructured":"Thomas S, Fisher KH, Snowden JA, Danson SJ, Brown S, Zeidler MP (2015) Methotrexate is a JAK\/STAT pathway inhibitor. PLoS One 10(7):e0130078","journal-title":"PLoS One"},{"issue":"6","key":"5130_CR137","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.reuma.2012.05.006","volume":"8","author":"E Toledano","year":"2012","unstructured":"Toledano E, Candelas G, Rosales Z, Prada CM, Le\u00f3n L, Ab\u00e1solo L, Loza E, Carmona L, Tob\u00edas A, Jover J\u00c1 (2012) A meta-analysis of mortality in rheumatic diseases. Reumatol Clin 8(6):334\u2013341","journal-title":"Reumatol Clin"},{"issue":"6","key":"5130_CR138","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14216","volume":"33","author":"F Topalo\u011flu Demir","year":"2020","unstructured":"Topalo\u011flu Demir F, \u00d6zk\u00f6k Akbulut T, K\u0131van\u00e7 Altunay \u0130, Aytekin S, O\u011fuz Topal \u0130, Kara Polat A, \u00d6zkur E, Karada\u011f AS (2020) Evaluation of the adverse effects of biological agents used in the treatment of psoriasis: a multicenter retrospective cohort study. Dermatol Ther 33(6):e14216","journal-title":"Dermatol Ther"},{"issue":"2","key":"5130_CR139","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0168-3659(01)00299-1","volume":"73","author":"VP Torchilin","year":"2001","unstructured":"Torchilin VP (2001) Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 73(2):137\u2013172","journal-title":"J Control Release"},{"issue":"8","key":"5130_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081284","volume":"13","author":"AV Torres-Figueroa","year":"2021","unstructured":"Torres-Figueroa AV, P\u00e9rez-Mart\u00ednez CJ, Encinas JC, Burruel-Ibarra S, Silvas-Garc\u00eda MI, Garc\u00eda Alegr\u00eda AM, del Castillo-Castro T (2021) Thermosensitive bioadhesive hydrogels based on poly (n-isopropylacrilamide) and poly (methyl vinyl ether-alt-maleic anhydride) for the controlled release of metronidazole in the vaginal environment. Pharmaceutics 13(8):1284","journal-title":"Pharmaceutics"},{"issue":"4","key":"5130_CR141","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1021\/ma102572s","volume":"44","author":"G Van Assche","year":"2011","unstructured":"Van Assche G, Van Mele B, Li T, Nies E (2011) Adjacent UCST phase behavior in aqueous solutions of poly (vinyl methyl ether): detection of a narrow low temperature UCST in the lower concentration range. Macromolecules 44(4):993\u2013998","journal-title":"Macromolecules"},{"issue":"1","key":"5130_CR142","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-bioeng-092419-061127","volume":"22","author":"AK Varanko","year":"2020","unstructured":"Varanko AK, Su JC, Chilkoti A (2020) Elastin-like polypeptides for biomedical applications. Annu Rev Biomed Eng 22(1):343\u2013369","journal-title":"Annu Rev Biomed Eng"},{"key":"5130_CR143","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1537689","author":"G Wang","year":"2020","unstructured":"Wang G, Peng X (2020) A review of clinical applications and side effects of methotrexate in ophthalmology. J Ophthalmol. https:\/\/doi.org\/10.1155\/2020\/1537689","journal-title":"J Ophthalmol"},{"key":"5130_CR144","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s225613","author":"L Wang","year":"2019","unstructured":"Wang L, Huang S, Li S, Li M, Shi J, Bai W, Wang Q, Zheng L, Liu Y (2019) Efficacy and safety of umbilical cord mesenchymal stem cell therapy for rheumatoid arthritis patients: a prospective phase I\/II study. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/dddt.s225613","journal-title":"Drug Des Devel Ther"},{"key":"5130_CR145","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s256850","author":"Q-S Wang","year":"2020","unstructured":"Wang Q-S, Xu B-X, Fan K-J, Li Y-W, Wu J, Wang T-Y (2020) Dexamethasone-loaded thermosensitive hydrogel suppresses inflammation and pain in collagen-induced arthritis rats. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/dddt.s256850","journal-title":"Drug Des Devel Ther"},{"key":"5130_CR146","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.12659\/MSM.895116","volume":"21","author":"S-T Wei","year":"2015","unstructured":"Wei S-T, Sun Y-H, Zong S-H, Xiang Y-B (2015) Serum levels of IL-6 and TNF-\u03b1 may correlate with activity and severity of rheumatoid arthritis. Med Sci Monit 21:4030","journal-title":"Med Sci Monit"},{"issue":"10","key":"5130_CR147","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3390\/pharmaceutics12100919","volume":"12","author":"J Weiss","year":"2020","unstructured":"Weiss J, Bajraktari-Sylejmani G, Haefeli WE (2020) Interaction of hydroxychloroquine with pharmacokinetically important drug transporters. Pharmaceutics 12(10):919","journal-title":"Pharmaceutics"},{"key":"5130_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00939","volume":"11","author":"H Wen","year":"2020","unstructured":"Wen H, Chen D, Lu J, Jiao Z, Chen B, Zhang B, Ye C, Liu L (2020) Probable drug interaction between etanercept and cyclosporine resulting in clinically unexpected low trough concentrations: first case report. Front Pharmacol 11:939","journal-title":"Front Pharmacol"},{"issue":"15","key":"5130_CR149","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.2174\/1381612821666150302151959","volume":"21","author":"L Weng","year":"2015","unstructured":"Weng L, Xie J (2015) Smart electrospun nanofibers for controlled drug release: recent advances and new perspectives. Curr Pharm Des 21(15):1944\u20131959","journal-title":"Curr Pharm Des"},{"issue":"9","key":"5130_CR150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003252","volume":"17","author":"NJ White","year":"2020","unstructured":"White NJ, Watson JA, Hoglund RM, Chan XHS, Cheah PY, Tarning J (2020) COVID-19 prevention and treatment: a critical analysis of chloroquine and hydroxychloroquine clinical pharmacology. PLoS Med 17(9):e1003252","journal-title":"PLoS Med"},{"key":"5130_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.111581","volume":"200","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Gu Y, Qin L, Chen L, Chen X, Cui W, Li F, Xiang N, He X (2021) Injectable thermosensitive hydrogel-based drug delivery system for local cancer therapy. Colloids Surf B Biointerfaces 200:111581","journal-title":"Colloids Surf B Biointerfaces"},{"key":"5130_CR152","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.jconrel.2024.11.009","volume":"376","author":"J Xing","year":"2024","unstructured":"Xing J, Jia J, Zhang H, Han H, Li Q (2024) Fluorinated dendrimer-mediated miR-30a delivery regulates the inflammation of macrophages and mitigates the symptoms of rheumatoid arthritis. J Control Release 376:1143\u20131159","journal-title":"J Control Release"},{"issue":"9","key":"5130_CR153","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1177\/0091270009339192","volume":"49","author":"Z Xu","year":"2009","unstructured":"Xu Z, Vu T, Lee H, Hu C, Ling J, Yan H, Baker D, Beutler A, Pendley C, Wagner C, Davis HM, Zhou H (2009) Population pharmacokinetics of golimumab, an anti-tumor necrosis factor-\u03b1 human monoclonal antibody, in patients with psoriatic arthritis. J Clin Pharmacol 49(9):1056\u20131070","journal-title":"J Clin Pharmacol"},{"key":"5130_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-020-00675-6","volume":"18","author":"F Yan","year":"2020","unstructured":"Yan F, Zhong Z, Wang Y, Feng Y, Mei Z, Li H, Chen X, Cai L, Li C (2020) Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis. J Nanobiotechnology 18:1\u201315","journal-title":"J Nanobiotechnology"},{"key":"5130_CR155","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijbiomac.2019.12.019","volume":"143","author":"X Yang","year":"2020","unstructured":"Yang X, Li Z, Liu H, Ma L, Huang X, Cai Z, Xu X, Shang S, Song Z (2020) Cellulose-based polymeric emulsifier stabilized poly (N-vinylcaprolactam) hydrogel with temperature and pH responsiveness. Int J Biol Macromol 143:190\u2013199","journal-title":"Int J Biol Macromol"},{"key":"5130_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102389","volume":"57","author":"N Yang","year":"2024","unstructured":"Yang N, Ma T, Wang W, Sun J, Zhang X, Hu J, Zhu C (2024) Carbon monoxide (CO)-releasing micelles enable efficient treatment of MRSA-induced septic arthritis and rheumatoid arthritis. Nano Today 57:102389","journal-title":"Nano Today"},{"issue":"5","key":"5130_CR157","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1039\/C9TB01795J","volume":"8","author":"N Yin","year":"2020","unstructured":"Yin N, Guo X, Sun R, Liu H, Tang L, Gou J, Yin T, He H, Zhang Y, Tang X (2020) Intra-articular injection of indomethacin\u2013methotrexate in situ hydrogel for the synergistic treatment of rheumatoid arthritis. J Mater Chem B 8(5):993\u20131007","journal-title":"J Mater Chem B"},{"key":"5130_CR158","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.intimp.2019.05.042","volume":"73","author":"Q Yu","year":"2019","unstructured":"Yu Q, Tong Y, Cui L, Zhang L, Gong Y, Diao H, Gao F, Shi Y (2019) Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis. Int Immunopharmacol 73:442\u2013450","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5130_CR159","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1007\/s13346-021-00992-9","volume":"11","author":"M Zewail","year":"2021","unstructured":"Zewail M, Nafee N, Helmy MW, Boraie N (2021) Synergistic and receptor-mediated targeting of arthritic joints via intra-articular injectable smart hydrogels containing leflunomide-loaded lipid nanocarriers. Drug Deliv Transl Res 11(6):2496\u20132519","journal-title":"Drug Deliv Transl Res"},{"issue":"24","key":"5130_CR160","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1039\/D4BM01058B","volume":"12","author":"MB Zewail","year":"2024","unstructured":"Zewail MB, Doghish AS, El-Husseiny HM, Mady EA, Mohammed OA, Elbadry AMM, Elbokhomy AS, Bhnsawy A, El-Dakroury WA (2024) Lipid-based nanocarriers: an attractive approach for rheumatoid arthritis management. Biomater Sci 12(24):6163\u20136195","journal-title":"Biomater Sci"},{"key":"5130_CR161","volume-title":"Switchable and responsive surfaces and materials for biomedical applications","author":"J Zhang","year":"2014","unstructured":"Zhang J (2014) Switchable and responsive surfaces and materials for biomedical applications. Elsevier"},{"key":"5130_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124822","author":"R Zhang","year":"2023","unstructured":"Zhang R, Liu F, Zhang Q, Yang L, Hou X, Du T, Fan J, Hu H, Deng H, Hao L (2023) Intra-articular delivery system of methotrexate for rheumatoid arthritis therapy: an in-suit thermosensitive comprehensive gel of polysaccharide from Aconitum carmichaelii Debx. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124822","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"5130_CR163","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03110-w","volume":"23","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Wang G, Zhang Z, Liang X, Wang G, Xu M, Yang X, Zhong X, Li C, Zhou M (2025) Locally administered liposomal drug depot enhances rheumatoid arthritis treatment by inhibiting inflammation and promoting cartilage repair. J Nanobiotechnology 23(1):69","journal-title":"J Nanobiotechnology"},{"key":"5130_CR164","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.actbio.2020.12.005","volume":"121","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Gao C, Liu H, Liu H, Feng Y, Li Z, Liu H, Wang J, Yang B, Lin Q (2021) Infliximab-based self-healing hydrogel composite scaffold enhances stem cell survival, engraftment, and function in rheumatoid arthritis treatment. Acta Biomater 121:653\u2013664","journal-title":"Acta Biomater"},{"key":"5130_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113074","volume":"150","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Hua Z, Luo X, Li Y, Yu L, Li M, Lu C, Zhao T, Liu Y (2022) Application and pharmacological mechanism of methotrexate in rheumatoid arthritis. Biomed Pharmacother 150:113074","journal-title":"Biomed Pharmacother"},{"issue":"16","key":"5130_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25163731","volume":"25","author":"A Zieli\u0144ska","year":"2020","unstructured":"Zieli\u0144ska A, Carreir\u00f3 F, Oliveira AM, Neves A, Pires B, Venkatesh DN, Durazzo A, Lucarini M, Eder P, Silva AM (2020) Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules 25(16):3731","journal-title":"Molecules"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05130-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:04:40Z","timestamp":1781514280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05130-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":166,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5130"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05130-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}